Have a personal or library account? Click to login
Anticoagulation for Left Ventricular Thrombosis Post-Myocardial Infarction – Current Recommendations and Future Perspectives Cover

Anticoagulation for Left Ventricular Thrombosis Post-Myocardial Infarction – Current Recommendations and Future Perspectives

Romanian Journal of Cardiology
Volume 32 (2022): Issue 1 (March 2022)
By: Mihai Ștefan Cristian Haba,  Andreea-Simona Ungurenașu,  Elena Cosmina Ciobanu,  Florin Mitu,  Radu Stefan Miftode and  Ovidiu Mitu  
Open Access
|Jun 2022

References

  1. Cruz Rodriguez JB, Okajima K, Greenberg BH. Management of left ventricular thrombus: a narrative review. Ann Transl Med. 2021;9(6):520.
    Search in Google ScholarBack to article
  2. Camilli M, Lombardi M, Del Buono MG, et al. Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2021;7(3):e21–5.
    Search in Google ScholarBack to article
  3. Massussi M, Scotti A, Lip GYH, Proietti R. Left ventricular thrombosis: new perspectives on an old problem. Eur Heart J Cardiovasc Pharmacother. 2021;7(2):158–67.
    Search in Google ScholarBack to article
  4. Matsumoto M, Takei N, Mineki T, Yahata T, Oiwa K. Anticoagulant therapy with dual antiplatelet for left ventricular thrombus following acute myocardial infarction. J Cardiol Cases. 2020;22(3):114–6.
    Search in Google ScholarBack to article
  5. Delewi R, Zijlstra F, Piek JJ. Left ventricular thrombus formation after acute myocardial infarction. Heart. 2012;98(23):1743–9.
    Search in Google ScholarBack to article
  6. Keren A, Goldberg S, Gottlieb S, et al. Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol. 1990;15(4):790–800.
    Search in Google ScholarBack to article
  7. Weinsaft JW, Kim J, Medicherla CB, et al. Echocardiographic algorithm for post-myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR. JACC Cardiovasc Imaging. 2016;9(5):505–15.
    Search in Google ScholarBack to article
  8. Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152(1):75–84.
    Search in Google ScholarBack to article
  9. Barbieri A, Mantovani F, Bursi F, Faggiano A, Boriani G, Faggiano P. Optimal use of echocardiography in management of thrombosis after anterior myocardial infarction. Echocardiography. 2020;37(8):1287–95.
    Search in Google ScholarBack to article
  10. Anwar AM, Nosir YFM, Ajam A, Chamsi-Pasha H. Central role of real-time three-dimensional echocardiography in the assessment of intracardiac thrombi. Int J Cardiovasc Imaging. 2010;26(5):519–26.
    Search in Google ScholarBack to article
  11. Joseph P. Mathew, Ayoub, Chakib M., Alina Nicoara, and Madhav Swaminathan, Eds. Clinical Manual and Review of Transesophageal Echocardiography, Third edition. McGraw-Hill Education, New York, 2019.
    Search in Google ScholarBack to article
  12. Bulluck H, Chan MHH, Paradies V, et al. Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis. J Cardiovasc Magn Reson. 2018;20(1):72.
    Search in Google ScholarBack to article
  13. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guidelines for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):529–55.
    Search in Google ScholarBack to article
  14. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–236.
    Search in Google ScholarBack to article
  15. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–77.
    Search in Google ScholarBack to article
  16. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–228.
    Search in Google ScholarBack to article
  17. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–467.
    Search in Google ScholarBack to article
  18. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):7S–47S.
    Search in Google ScholarBack to article
  19. Kontny F, Dale J, Abildgaard U, Hegrenaes L, Lem P, Morstøl T. Adverse effect of warfarin in acute myocardial infarction: increased left ventricular thrombus formation in patients not treated with high-dose heparin. Eur Heart J. 1993;14(8):1040–3.
    Search in Google ScholarBack to article
  20. Ebrahimi M, Fazlinezhad A, Alvandi-Azari M, Abdar Esfahani M. Long-term clinical outcomes of the left ventricular thrombus in patients with ST-elevation anterior myocardial infarction. ARYA Atheroscler. 2015;11(1):1–4.
    Search in Google ScholarBack to article
  21. Mearns ES, White CM, Kohn CG, et al. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thromb J. 2014;12:14.
    Search in Google ScholarBack to article
  22. Ansell J, Hollowell J, Pengo V, Martinez-Brotons F, Caro J, Drouet L. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM). J Thromb Thrombolysis. 2007;23(2):83–91.
    Search in Google ScholarBack to article
  23. Franco Moreno AI, Martín Díaz RM, García Navarro MJ. Direct oral anticoagulants: An update. Med Clin (Barc). 2018;151(5):198–206.
    Search in Google ScholarBack to article
  24. Tran PN, Tran M-H. Emerging role of direct oral anticoagulants in the management of heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2018;24(2):201–9.
    Search in Google ScholarBack to article
  25. Cohen H, Efthymiou M, Isenberg DA. Use of direct oral anticoagulants in antiphospholipid syndrome. J Thromb Haemost. 2018;16(6):1028–39.
    Search in Google ScholarBack to article
  26. Skelley JW, White CW, Thomason AR. The use of direct oral anticoagulants in inherited thrombophilia. J Thromb Thrombolysis. 2017;43(1):24–30.
    Search in Google ScholarBack to article
  27. Cochran JM, Jia X, Hamzeh I, Birnbaum Y. Abstract 16411: Direct oral anticoagulant use for left ventricular thrombus: a single-center experience. Circulation. 2018;138:A16411.
    Search in Google ScholarBack to article
  28. Fleddermann AM, Hayes CH, Magalski A, Main ML. Efficacy of direct-acting oral anticoagulants in treatment of left ventricular thrombus. Am J Cardiol. 2019;124(3):367–72.
    Search in Google ScholarBack to article
  29. Daher J, Da Costa A, Hilaire C, et al. Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists. Clin Drug Investig. 2020;40(4):343–53.
    Search in Google ScholarBack to article
  30. Guddeti RR, Anwar M, Walters RW, et al. Treatment of left ventricular thrombus with direct oral anticoagulants: a retrospective observational study. Am J Med. 2020;133(12):1488–91.
    Search in Google ScholarBack to article
  31. Robinson A, Ruth B, Dent J. Direct oral anticoagulants compared to warfarin for left ventricular thrombi: a single-center experience. J Am Coll Cardiol. 2018;71(11):A981.
    Search in Google ScholarBack to article
  32. Smetana KS, Dunne J, Parrott K, et al. Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series. J Thromb Thrombolysis. 2017;44(4):519–24.
    Search in Google ScholarBack to article
  33. Ali Z, Isom N, Dalia T, et al. Direct oral anticoagulant use in left ventricular thrombus. Thromb J. 2020;18:29.
    Search in Google ScholarBack to article
  34. Robinson AA, Trankle CR, Eubanks G, et al. Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi. JAMA Cardiol. 2020;5(6):685–92.
    Search in Google ScholarBack to article
  35. Alcalai R, Butnaru A, Moravsky G, et al. Apixaban versus warfarin in patients with left ventricular thrombus, a prospective multicenter randomized clinical trial. Eur Heart J Cardiovasc Pharmacother. 2021; Jul 19;pvab057. doi: 10.1093/ehjcvp/pvab057. Online ahead of print.
    Open DOISearch in Google ScholarBack to article
  36. Abdelnabi M, Saleh Y, Fareed A, et al. Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial). J Am Coll Cardiol. 2021;77(12):1590–2.
    Search in Google ScholarBack to article
  37. Michael F, Natt N, Shurrab M. Direct oral anticoagulants vs vitamin K antagonists in left ventricular thrombi: a systematic review and meta-analysis. CJC Open. 2021;3(9):1169–81.
    Search in Google ScholarBack to article
  38. Gibson CM, Mehran R, Bode C, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med. 2016;375(25):2423–34.
    Search in Google ScholarBack to article
  39. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213–60.
    Search in Google ScholarBack to article
  40. Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus. Ther AdvCardiovasc Dis. 2017;11(8):203–13.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/rjc-2022-0005 | Journal eISSN: 2734-6382 | Journal ISSN: 1220-658X
Journal RSS Feed
Language: English
Page range: 22 - 27
Published on: Jun 4, 2022
Published by: Romanian Society of Cardiology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Left ventricular thrombosis,
vitamin K antagonists,
direct oral anticoagulants,
anticoagulation,
treatment
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Cardiology,
Pediatrics and juvenile medicine,
Paediatric cardiology,
Surgery,
Cardiac surgery

© 2022 Mihai Ștefan Cristian Haba, Andreea-Simona Ungurenașu, Elena Cosmina Ciobanu, Florin Mitu, Radu Stefan Miftode, Ovidiu Mitu, published by Romanian Society of Cardiology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 32 (2022): Issue 1 (March 2022)Next article